Researchers report on the long-term immune changes in patients with refractory or relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax and rituximab plus bendamustine and rituximab.

Rapid Response Team of Maharashtra meets representatives of private hospitals in Pune on Thursday following reports of rise ...

IGM Biosciences has collaboration deal with Sanofi inked in 2022 and its stock has almost doubled in 2024 year to date. Read ...

One of the main sources of community- and hospital-acquired infections is Staphylococcus aureus, well known for its ...

Staphylococcus aureus, mostly known from its antibiotic-resistant variant Methicillin-resistant Staphylococcus aureus (MRSA), is among the leading causes of both community- and hospital-acquired ...

An international collaboration of researchers in Europe and the U.S. has identified a critical immune factor for host defense against Staphylococcus aureus, which could offer a potential explanation ...

Staphylococcus aureus, mostly known from its antibiotic-resistant variant methicillin-resistant Staphylococcus aureus (MRSA), ...

Staphylococcus aureus, mostly known from its antibiotic-resistant variant Methicillin-resistant Staphylococcus aureus (MRSA), ...

In this study we propose that this might not be the answer. We show that not IgG, but IgM antibodies are required for ...

IGM Biosciences Inc’s IGMS share price has surged by 28.78%, which has investors questioning if this is right time to sell.